Masashi Hirayama

Integrated molecular profiling of juvenile myelomonocytic leukemia

Norihiro Murakami, Yusuke Okuno, Kenichi Yoshida et al. · Blood · 2018 · 102 citations · Full text

GPR40‐induced insulin secretion by the novel agonist TAK‐875: first clinical findings in patients with type 2 diabetes

Tsuyoshi Araki, Masashi Hirayama, Shinzo Hiroi et al. · Diabetes Obesity and Metabolism · 2011 · 96 citations

Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled trial with an open‐label long‐term extension study

Kohei Kaku, T. Itayasu, Shinzo Hiroi et al. · Diabetes Obesity and Metabolism · 2011 · 84 citations

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

Yutaka Seino, Tetsuya Fujita, Shinzo Hiroi et al. · Current Medical Research and Opinion · 2011 · 77 citations

Metabolic Syndrome, Adverse Events, Diabetes Management +14

Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled trial with an open‐label, long‐term extension study

Yutaka Seino, Yuko Miyata, Shinzo Hiroi et al. · Diabetes Obesity and Metabolism · 2012 · 58 citations